{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:07:26Z","timestamp":1786993646175,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.leukres.2017.05.009","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T22:15:33Z","timestamp":1494627333000},"page":"8-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["A rare e13a3 (b2a3) BCR-ABL1 fusion transcript with normal karyotype in chronic myeloid leukemia: The challenges in diagnosis and monitoring minimal residual disease (MRD)"],"prefix":"10.1016","volume":"59","author":[{"given":"M.-H.","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.leukres.2017.05.009_bib0005","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","article-title":"European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013","volume":"122","author":"Baccarani","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2017.05.009_bib0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bjhh.2014.07.006","article-title":"Diversity of breakpoints of variant Philadelphia chromosomes in chronic myeloid leukemia in Brazilian patients","volume":"37","author":"Chauffaille","year":"2015","journal-title":"Rev. Bras. Hematol. Hemoter."},{"issue":"1","key":"10.1016\/j.leukres.2017.05.009_bib0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1128\/MCB.5.1.204","article-title":"Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties","volume":"5","author":"Davis","year":"1985","journal-title":"Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.leukres.2017.05.009_bib0020","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood.V88.7.2410.bloodjournal8872410","article-title":"Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR\/ABL with C3\/A2 junction)","volume":"88","author":"Pane","year":"1996","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2017.05.009_bib0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0950-3536(97)80003-0","article-title":"BCR-ABL gene variants","volume":"10","author":"Melo","year":"1997","journal-title":"Baillieres Clin. Haematol."},{"issue":"25","key":"10.1016\/j.leukres.2017.05.009_bib0030","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1182\/blood-2011-01-328294","article-title":"Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA working party on CML analysis","volume":"117","author":"Marzocchi","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2017.05.009_bib0035","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1182\/blood.V81.12.3365.3365","article-title":"Application of chromosome microdissection probes for elucidation of BCR-ABL fusion and variant Philadelphia chromosome translocations in chronic myelogenous leukemia","volume":"81","author":"Zhang","year":"1993","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2017.05.009_bib0040","doi-asserted-by":"crossref","first-page":"533","DOI":"10.47102\/annals-acadmedsg.V34N9p533","article-title":"The incidence and patterns of BCR\/ABL rearrangements in chronic myeloid leukaemia (CML) using fluorescence in situ hybridisation (FISH)","volume":"34","author":"Lim","year":"2005","journal-title":"Ann. Acad. Med. Singapore"},{"issue":"2","key":"10.1016\/j.leukres.2017.05.009_bib0045","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s12185-009-0368-4","article-title":"A chronic myeloid leukemia patient with a typical karyotype and BCR-ABL e13a3 transcript caused by complex chromosome rearrangement","volume":"90","author":"Masuko","year":"2009","journal-title":"Int. J. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2017.05.009_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(03)00202-4","article-title":"A novel tricolor, dual-fusion fluorescence in situ hybridization method to detect BCR\/ABL fusion in cells with t(9;22)(q34;q11.2) associated with deletion of DNA on the derivative chromosome 9 in chronic myelocytic leukemia","volume":"148","author":"Smoley","year":"2004","journal-title":"Cancer Genet. Cytogenet."},{"issue":"6","key":"10.1016\/j.leukres.2017.05.009_bib0055","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3892\/ol.2010.180","article-title":"Insertion of the 3' ABL region into the long arm of chromosome 1 in a Philadelphia chromosome-negative chronic myeloid leukemia case","volume":"1","author":"Al-Achkar","year":"2010","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.leukres.2017.05.009_bib0060","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.3892\/mmr.2016.4826","article-title":"Complete cytogenetic response to Nilotinib in a chronic myeloid leukemia case with a rare e13a3(b2a3) BCR-ABL fusion transcript: a case report","volume":"13","author":"Liu","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.leukres.2017.05.009_bib0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ajh.10456","article-title":"Chronic myeloid leukemia with an e13a3 BCR-ABL fusion: benign course responsive to imatinib with an RT-PCR advisory","volume":"75","author":"Snyder","year":"2004","journal-title":"Am. J. Hematol."},{"issue":"8","key":"10.1016\/j.leukres.2017.05.009_bib0070","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1084\/jem.189.8.1229","article-title":"Signal transducer and activator of transcription (STAT)5 activation by BCR\/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR\/ABL and is required for leukemogenesis","volume":"189","author":"Nieborowska-Skorska","year":"1999","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.leukres.2017.05.009_bib0075","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.leukres.2005.04.001","article-title":"CML patient with rare b 2 a 3 (e 13 a 3) variant of BCR-ABL transcript: complete molecular response to imatinib","volume":"29","author":"Moravcova","year":"2005","journal-title":"Leuk. Res."},{"issue":"4","key":"10.1016\/j.leukres.2017.05.009_bib0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2353\/jmoldx.2009.090008","article-title":"A rare e14a3 (b3a3) BCR-ABL fusion transcript in chronic myeloid leukemia: diagnostic challenges in clinical laboratory practice","volume":"11","author":"Jinawath","year":"2009","journal-title":"J. Mol. Diagn."},{"issue":"2","key":"10.1016\/j.leukres.2017.05.009_bib0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cancergencyto.2006.11.021","article-title":"Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript","volume":"174","author":"Pienkowska-Grela","year":"2007","journal-title":"Cancer Genet. Cytogenet."},{"issue":"4","key":"10.1016\/j.leukres.2017.05.009_bib0090","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.leukres.2007.08.017","article-title":"A multiplex PCR for improved detection of typical and a typical BCR-ABL fusion transcripts","volume":"32","author":"Burmeister","year":"2008","journal-title":"Leuk. Res."},{"issue":"2","key":"10.1016\/j.leukres.2017.05.009_bib0095","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12032-014-0452-3","article-title":"Molecular response to imatinib in chronic myeloid leukaemia with a variant e13a3 BCR-ABL1 fusion","volume":"32","author":"McCarron","year":"2015","journal-title":"Med. Oncol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521261730423X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521261730423X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T10:59:57Z","timestamp":1750244397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014521261730423X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":19,"alternative-id":["S014521261730423X"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.05.009","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A rare e13a3 (b2a3) BCR-ABL1 fusion transcript with normal karyotype in chronic myeloid leukemia: The challenges in diagnosis and monitoring minimal residual disease (MRD)","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}